Skip to content
10-Q

Quarterly Report

Shockwave Medical, Inc.

0001642545-24-000091

← back to feed
Filed
May 6, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 1, 2024 37.54M sh
Shares Diluted Q1 2024 · Mar 31, 2024 38.47M sh
Shares Diluted Q1 2024 · Mar 31, 2023 37.98M sh
Capex Q1 2024 · Mar 31, 2024 $8.39M
Capex Q1 2024 · Mar 31, 2023 $7.19M
Operating Cash Flow Q1 2024 · Mar 31, 2024 $35.84M
Operating Cash Flow Q1 2024 · Mar 31, 2023 $33.96M
Short Term Investments Q1 2024 · Mar 31, 2024 $747.56M
Short Term Investments Q1 2024 · Dec 31, 2023 $662.13M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $281.67M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $328.42M
Cash And Equivalents Q1 2024 · Mar 31, 2023 $280.93M
Stockholders Equity Q1 2024 · Mar 31, 2024 $751.76M
Stockholders Equity Q1 2024 · Dec 31, 2023 $668.68M
Stockholders Equity Q1 2024 · Mar 31, 2023 $570.69M
Stockholders Equity Q1 2024 · Dec 31, 2022 $511.32M
Current Liabilities Q1 2024 · Mar 31, 2024 $92.33M
Current Liabilities Q1 2024 · Dec 31, 2023 $104.21M
Total Liabilities Q1 2024 · Mar 31, 2024 $891.99M
Total Liabilities Q1 2024 · Dec 31, 2023 $897.89M
Current Assets Q1 2024 · Mar 31, 2024 $1.28B
Current Assets Q1 2024 · Dec 31, 2023 $1.23B
Total Assets Q1 2024 · Mar 31, 2024 $1.64B
Total Assets Q1 2024 · Dec 31, 2023 $1.57B
Eps Diluted Q1 2024 · Mar 31, 2024 $1.44
Eps Diluted Q1 2024 · Mar 31, 2023 $1.03
Eps Basic Q1 2024 · Mar 31, 2024 $1.48
Eps Basic Q1 2024 · Mar 31, 2023 $1.07
Sga Expense Q1 2024 · Mar 31, 2024 $29.23M
Sga Expense Q1 2024 · Mar 31, 2023 $19.2M
Rd Expense Q1 2024 · Mar 31, 2024 $44.47M
Rd Expense Q1 2024 · Mar 31, 2023 $26.97M
Net Income Q1 2024 · Mar 31, 2024 $55.35M
Net Income Q1 2024 · Mar 31, 2023 $39.13M
Operating Income Q1 2024 · Mar 31, 2024 $42.41M
Operating Income Q1 2024 · Mar 31, 2023 $39.81M
Gross Profit Q1 2024 · Mar 31, 2024 $190.6M
Gross Profit Q1 2024 · Mar 31, 2023 $140M
Cost Of Revenue Q1 2024 · Mar 31, 2024 $28.21M
Cost Of Revenue Q1 2024 · Mar 31, 2023 $21.07M
Revenue Q1 2024 · Mar 31, 2024 $218.81M
Revenue Q1 2024 · Mar 31, 2023 $161.07M